首页> 外文期刊>The journal of sexual medicine >CME Multiple Choice Questions
【24h】

CME Multiple Choice Questions

机译:芝商所多项选择题

获取原文
获取原文并翻译 | 示例
           

摘要

1. Among men with concerns over ejaculatory control, clinical utility for all of the following has been demonstrated EXCEPT: a. Tricyclic antidepressents b. Selective serotonin uptake inhibitors c. Topical anesthetics d. Alpha agonists 2. The development of secondary premature ejaculation (PE) among men who develop erectile dysfunction (ED) is: a. Very unusual b. Often is believed to occur in men who have Peyronie's disease c. Amendable to treatment with phosphodi-esterase type 5 inhibitor (PDE5i) d. Typically transient 3. The potential risk associated with the co-administration of a selective serotonin reuptake inhibitor (SSRI) and coumadin is: a. Inactivity of the anti-thrombotic effect b. Enhanced side effects related to metabolic changes of the SSRI c. Prolonged bleeding potential d. Elevation of serotonin levels
机译:1.在担心射精控制的男性中,除以下各项外,以下所有方面的临床效用均得到证实:三环类抗抑郁药b。选择性5-羟色胺摄取抑制剂c。局部麻醉药d。阿尔法激动剂2.在发展勃起功能障碍(ED)的男性中,继发性早泄(PE)的发展是:非常不寻常b。据信通常发生在患有Peyronie病的男性中c。可以修改为5型磷酸二酯酶抑制剂(PDE5i)d。通常是短暂的。3.与选择性5-羟色胺再摄取抑制剂(SSRI)和香豆素共同给药相关的潜在风险是:无效的抗血栓形成作用b。与SSRI的代谢变化有关的增强的副作用c。潜在的出血时间延长d。血清素水平升高

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号